Dice Molecules Holdings Stock Earnings Per Share
Dice Molecules Holdings fundamentals help investors to digest information that contributes to Dice Molecules' financial success or failures. It also enables traders to predict the movement of Dice Stock. The fundamental analysis module provides a way to measure Dice Molecules' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dice Molecules stock.
Dice |
Dice Molecules Holdings Company Earnings Per Share Analysis
Dice Molecules' Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Dice Molecules Earnings Per Share | (2.17) X |
Most of Dice Molecules' fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dice Molecules Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, Dice Molecules Holdings has an Earnings Per Share of -2.17 times. This is 125.93% lower than that of the Pharmaceuticals sector and 54.7% lower than that of the Health Care industry. The earnings per share for all United States stocks is 169.55% higher than that of the company.
Dice Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dice Molecules' direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dice Molecules could also be used in its relative valuation, which is a method of valuing Dice Molecules by comparing valuation metrics of similar companies.Dice Molecules is currently under evaluation in earnings per share category among its peers.
Dice Fundamentals
| Return On Equity | -0.22 | |||
| Return On Asset | -0.14 | |||
| Current Valuation | 2.27 B | |||
| Shares Outstanding | 47.76 M | |||
| Shares Owned By Insiders | 3.15 % | |||
| Shares Owned By Institutions | 96.85 % | |||
| Number Of Shares Shorted | 4.88 M | |||
| Price To Book | 5.91 X | |||
| Price To Sales | 699.00 X | |||
| Gross Profit | (56.08 M) | |||
| EBITDA | (83.01 M) | |||
| Net Income | (83.89 M) | |||
| Cash And Equivalents | 282.22 M | |||
| Cash Per Share | 7.39 X | |||
| Total Debt | 13.27 M | |||
| Debt To Equity | 0.05 % | |||
| Current Ratio | 23.61 X | |||
| Book Value Per Share | 11.88 X | |||
| Cash Flow From Operations | (64.32 M) | |||
| Short Ratio | 1.26 X | |||
| Earnings Per Share | (2.17) X | |||
| Price To Earnings To Growth | 0.84 X | |||
| Target Price | 49.83 | |||
| Number Of Employees | 71 | |||
| Market Capitalization | 2.27 B | |||
| Total Asset | 593.98 M | |||
| Retained Earnings | (187.59 M) | |||
| Working Capital | 562.61 M | |||
| Net Asset | 593.98 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Dice Stock
If you are still planning to invest in Dice Molecules Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dice Molecules' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Correlations Find global opportunities by holding instruments from different markets |